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Is Thrombus Aspiration
the Appropriate “Remedy”?
The recently published substudy of the REMEDIA (Random-
ized Evaluation of the Effect of Mechanical Reduction of Distal
Embolization by Thrombus-Aspiration in Primary and Rescue
Angioplasty) trial by Galiuto et al. (1) raises a number of
important issues regarding routine use of thrombectomy devices
in the setting of acute ST-segment elevation myocardial infarc-
tion. To date, results from recently published larger randomized
studies of distal protection have shown a neutral effect (2–4).
Furthermore, relevant results were obtained in 2 of these studies
regarding an associated increase in infarct size (3,4).
The original REMEDIA trial (5), however, showed im-
proved myocardial blush grade and ST-segment resolution in
the thrombectomy arm. The Galiuto et al. (1) substudy of this
trial further evaluates potential mechanisms behind this finding.
In this substudy, patients were evaluated with myocardial
contrast echocardiography (MCE) at 24 h, 1 week, and 6
months, with consistent improvements seen over these time
periods, not only in microvascular but also myocardial function.
These results, though promising, should be viewed in light of
not only the previously published neutral studies, but also the
PROMISE (Protection Devices in PCI Treatment of Myocar-
dial Infarction for Salvage of Endangered Myocardium)
study (6).
Utilizing Doppler Flo-wire and cardiac magnetic resonance
imaging evaluation, the PROMISE study had neutral findings
regarding microvascular function and infarct size. Differences
between the Galiuto et al. (1) and PROMISE (6) studies are
important to note, particularly when evaluating their different
conclusions. It is possible that the microvascular circulation
following primary angioplasty remains dysfunctional in the
short term but begins to normalize over 12 to 24 h. This would
explain both the immediate postangioplasty neutral result of the
Doppler Flo-wire study and positive results of the MCE
evaluation over time. Furthermore, it is possible that initial
passage of a distal protection device (i.e., filter wire or distal
balloon occlusion device) may result in distal embolization, a
process that might be reduced with isolated thrombectomy
catheter use.
However, the major concern relates to the Galiuto et al. (1)
study being potentially underpowered. As no power calculations
were provided in this trial, we are unable to assess whether 50
patients is appropriate; of note, the negative PROMISE study
randomized 4 times more subjects.
Although the findings of the small Galiuto et al. (1) study are
promising, the weight of evidence of larger randomized trials
supports a neutral effect of distal protection on both microvascular
and myocardial function. Further evaluation of such devices is
imperative, particularly in selected cases such as those with large
angiographic thrombus burden.
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